期刊文献+

胆汁三烯结合蛋白在大肠杆菌中的表达、复性与纯化 被引量:1

Expression,Refolding and Purification of Bilin Binding Protein in Escherichia coli
下载PDF
导出
摘要 目的:合成胆汁三烯结合蛋白(BBP)基因并在大肠杆菌中表达,获得重组BBP纯化制品。方法:根据天然BBP的基因序列和大肠杆菌偏好密码子设计并合成BBP基因的引物,PCR扩增优化的BBP基因序列,克隆至载体pEasy-T3;测序正确后,将该序列克隆至表达载体pET-32a上,构建表达质粒,转化至大肠杆菌BL21(DE3)pLysS,在IPTG诱导下表达融合蛋白;采用Ni柱纯化融合蛋白。结果:PCR扩增获得了优化后的BBP基因序列,构建了表达载体pET-32a-BBP;SDS-PAGE分析表明表达的融合蛋白相对分子质量为20×103,以包涵体形式存在,占全菌蛋白的40%以上;变性、复性后经Ni2+柱纯化,获得纯度达98%以上的重组蛋白。结论:优化并合成了BBP全基因序列,获得了高纯度重组融合蛋白,为进一步鉴定其生物活性及筛选小分子的研究奠定了基础。 Objective: To synthesize bilin binding protein(BBP) gene sequence, express BBP efficiently in Escherichia coli and purify the recombinant protein. Methods: The primers were designed according to the natural BBP gene sequence and E.coli codon preference. The optimized sequence was amplified by PCR and was inserted into pEasy-T3. After determined by sequence analysis, the BBP gene was cloned into plasmid pET-32a to construct the expression vector pET-32a- BBP. The recombinant protein was over-expressed in E.coli BL21(DE3)pLysS and purified by immobilized metal ion affinity chromatography. Results: The BBP gene sequence was obtained by PCR. The expression plasmid named pET-32a-BBP was constructed and the recombinant protein was expressed in E.coli BL21 (DE3)pLysS as inclusion body, accounting for 40% of the total bacterial proteins. After denaturation and refolding, the fusion protein was successfully purified by Ni^2+ affinity chromatography. Conclusion: Purified recombinant BBP was obtained, determination of its biological activity and screening of small molecule binding protein are the next steps.
出处 《生物技术通讯》 CAS 2009年第2期191-194,共4页 Letters in Biotechnology
基金 国家科技支撑计划(2006BAK02A09) 天津市应用基础及前沿技术研究计划重点项目(09JCZDJC17700)
关键词 胆汁三烯结合蛋白 大肠杆菌 融合蛋白 bilin binding protein Escherichia eoli fusion protein
  • 相关文献

参考文献9

  • 1Liu G, Mills J L, Hess T A. Resonance assignments for the 21 kDa engineered fluorescein-binding lipocalin FluA [J]. J Biomol NMR, 2003,27(2):187-188.
  • 2Schlehuber S, Skerra A. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant - a so-called 'anticalin'- using a molecular random approach[J]. Biophys Chem, 2002,96(2-3):213-228.
  • 3Best G, Schmidt F S, Stibora T. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold[J]. J Proc Natl Acad Sci USA, 1999,96(5):1898-1903.
  • 4Schlehuber S, Beste G, Skerra A. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin[J]. J Mol Biol, 2000,297(5):1105-1120.
  • 5Komdorfer I P, Schlehuber S, Skerra A. Structural mechanism of specific ligand recognition by a lipocalin tailored for the complexation of digoxigenin[J]. J Mol Biol, 2003,330(2):385-396.
  • 6Mercader J V, Skerra A. Generation of anticalins with specificity for a nonsymmetric phthalic acid ester[J]. Anal Biochem, 2002,308 (2) : 269-277.
  • 7Skerra A.‘Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties[J]. J Biotechnol, 2001,74(4): 257-275.
  • 8Weiss G A, Lowman H B. Anticalins versus antibodies: made-to- order binding proteins forsmall molecules[J]. Chem Biol, 2000,7(8): R17784.
  • 9冯欣,刘刚,戴红梅,汤国营,游松.Scytovirin在大肠杆菌中的可溶性表达[J].生物技术通讯,2008,19(1):14-16. 被引量:1

二级参考文献7

  • 1奥斯伯 F.精编分子生物学实验指南[M].北京:科学出版社,1998.332-333.
  • 2Makrides S C. Strategies for achieving high-level expression of genes in Escherichia coli[J]. Microbiol Rev, 1996,60:512-538.
  • 3Choi J H, Lee S Y. Secretory and extracellular production of recombinant proteinsusing Escherichia coli [J]. Appl Microbiol Biotechnol, 2004,64:625-635.
  • 4Oka T, Sakarnoto S, Miyoshi K, et al. Synthesis and secretion of human epidermal growth factor by Escherichia coli[J]. Proc Natl Acad Sci, 1985,82:7212-7216.
  • 5Bokesch H R, O'Keefe B R, McKee T C, et al. A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium[J]. Biochemistry, 2003,42(9):2578-2584.
  • 6Adams E W, Ratner D M, Bokesch H R, et al. Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology: glycandependent gp120/protein interactions [J]. Chem Biol, 2004,11 (6): 875-881.
  • 7Gottesman S. Genetics of proteolysis in Escherichia coli[J].Annual Review Genetics, 1989,23:163-198.

同被引文献14

  • 1Amstutz P,Pelletier J N,Guggisberg A,et al.2002.In vitro selection for catalytic activity with ribosome display[J].Journal of the American Chemical Society,124(32):9396-9403.
  • 2Baranov V I,Morozov Z Y,Ortlepp S A.1989.Gene expression in cell-free system in preparation scale[J].Gene,84:63-66.
  • 3Beste G,Schmidt F S,Stibora T,et al.1999.Small antibodylike proteins with prescribed ligand specificities derived from the lipocalin fold[J].Proceedings of the National Academy of Sciences of the USA,96(5):1898-1903.
  • 4Binz H K,Amstutz P,Kohl A,et al.2004.High-affinity binders selected from designed ankyrin repeat protein libraries[J].Nature Biotechnology,22(4):575-582.
  • 5Hanes J,Plückthun A.1997.In vitro selection and evolution of functional proteins by using ribosome display[J].Proceedings of the National Academy of Sciences of the USA,94(10):4937-4942.
  • 6He M Y,Taussig M J.1997.Antibody-ribosome-mRNA(ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites[J].Nucleic Acids Research,25(24):5132-5134.
  • 7Lamla T,Erdmann V A.2001.In vitro selection of other proteins than antibodies by means of ribosome display[J].FEBS Letters,502(1-2):35-40.
  • 8Lamla T,Erdmann V A.2003.Searching sequence space for high affinity binding peptides using ribosome display[J].Joural of Molecular Biology,329(2):381-388.
  • 9Mattheakis L C,Bhatt R R,Dower W J.1994.An in vitro polysome display system for identifying ligands from very large peptide libraries[J].Proceedings of the National Academy of Sciences ofthe USA,91(19):9022-9026.
  • 10Schlehuber S,Beste G,Skerra A.2000.A novel type of receptor protein,based on the lipocalin scaffold,with specificity for digoxigenin[J].Journal of Molecular Biology,297(5):1105-1120.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部